Zantac Case Review

A Zantac lawsuit is a legal claim filed by people who developed cancer after taking Zantac and ranitidine tainted with NDMA. Zantac lawsuits seek compensation from the drug makers for cancers of the bladder, stomach, esophagus, liver, and pancreas that may have been caused by NDMA exposure.

Who Is Eligible to File a Lawsuit?​

People must meet several prerequisites, according to Zantac lawyers, in order to be eligible for a lawsuit: documented Zantac use, a cancer diagnosis, and a link between the disease and Zantac. Lawyers are only considering claims from persons who used the brand-name Zantac, and generic ranitidine is no longer covered.

Only a lawyer can correctly evaluate a claim, as well as assist in the collection of medical documents and data needed to develop a case.

Do I qualify?

Cancers that qualify for Zantac lawsuits include:

  • Bladder
  • Gastric/Stomach
  • Esophageal
  • Liver
  • Pancreatic

Questions and Answers?

Bladder, gastric/stomach, esophageal, liver and pancreatic.

Sanofi-Aventis U.S. LLC, Sanofi US Services Inc., Chattem, Inc., Boehringer Ingelheim, Pfizer and GlaxoSmithKline.

Initial stages, no trials scheduled.

Case Review

"*" indicates required fields

This field is for validation purposes and should be left unchanged.